Related Experiment Video
Updated: May 16, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Highly active anti-hepatitis C therapy: seven lessons from HIV
1Johns Hopkins School of Medicine, Baltimore, MD, USA. junk7900@verizon.net
Antiviral Therapy
|November 29, 2012
Summary
The new direct-acting antiviral treatments for Hepatitis C virus (HCV) offer hope, but lessons from the Human Immunodeficiency Virus (HIV) epidemic offer valuable insights for the current HCV treatment era.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- The advent of direct-acting antivirals (DAAs) marks a new era in Hepatitis C virus (HCV) treatment.
- The Human Immunodeficiency Virus (HIV) epidemic offers a historical parallel with potential lessons for HCV management.
Purpose of the Study:
- To examine seven key lessons learned from the HIV epidemic.
- To assess the applicability of these HIV lessons to the current HCV treatment landscape.
Main Methods:
- Comparative analysis of historical HIV management strategies.
- Extrapolation of established HIV treatment principles to emerging HCV therapies.
Main Results:
- Anticipated similarities exist between the HIV and HCV treatment experiences.
- Seven critical lessons from HIV management are relevant for optimizing HCV outcomes.
Conclusions:
- Proactive application of HIV-derived lessons can enhance the effectiveness of current HCV treatment strategies.
- Anticipating challenges and implementing proven strategies will be crucial for successful HCV eradication.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

